1. Home
  2. AMIX vs ENSC Comparison

AMIX vs ENSC Comparison

Compare AMIX & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMIX
  • ENSC
  • Stock Information
  • Founded
  • AMIX 2014
  • ENSC 2003
  • Country
  • AMIX United States
  • ENSC United States
  • Employees
  • AMIX N/A
  • ENSC N/A
  • Industry
  • AMIX
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMIX
  • ENSC Health Care
  • Exchange
  • AMIX NYSE
  • ENSC Nasdaq
  • Market Cap
  • AMIX 7.3M
  • ENSC 7.9M
  • IPO Year
  • AMIX N/A
  • ENSC N/A
  • Fundamental
  • Price
  • AMIX $3.46
  • ENSC $8.32
  • Analyst Decision
  • AMIX
  • ENSC
  • Analyst Count
  • AMIX 0
  • ENSC 0
  • Target Price
  • AMIX N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • AMIX 188.6K
  • ENSC 186.5K
  • Earning Date
  • AMIX 02-11-2025
  • ENSC 11-12-2024
  • Dividend Yield
  • AMIX N/A
  • ENSC N/A
  • EPS Growth
  • AMIX N/A
  • ENSC N/A
  • EPS
  • AMIX N/A
  • ENSC N/A
  • Revenue
  • AMIX N/A
  • ENSC $4,421,404.00
  • Revenue This Year
  • AMIX N/A
  • ENSC $12.04
  • Revenue Next Year
  • AMIX N/A
  • ENSC N/A
  • P/E Ratio
  • AMIX N/A
  • ENSC N/A
  • Revenue Growth
  • AMIX N/A
  • ENSC 40.41
  • 52 Week Low
  • AMIX $2.88
  • ENSC $2.12
  • 52 Week High
  • AMIX $152.00
  • ENSC $30.90
  • Technical
  • Relative Strength Index (RSI)
  • AMIX 34.39
  • ENSC 54.06
  • Support Level
  • AMIX $2.88
  • ENSC $5.96
  • Resistance Level
  • AMIX $3.60
  • ENSC $8.81
  • Average True Range (ATR)
  • AMIX 0.33
  • ENSC 1.11
  • MACD
  • AMIX 0.22
  • ENSC 0.09
  • Stochastic Oscillator
  • AMIX 45.90
  • ENSC 79.00

About AMIX AUTONOMIX MEDICAL INC

Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: